Grundläggande statistik
| CIK | 1427030 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to BioNeutral Group, Inc.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| April 20, 2016 |
BONU / BioNeutral Group, Inc. / Typenex Co-Investment, LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* BioNeutral Group, Inc (Name of Issuer) common stock, par value $0.00001 per share (Title of Class of Securities) 090621103 (CUSIP Number) April 20, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| January 28, 2015 |
BONU / BioNeutral Group, Inc. NT 10-K - - 10-K EXTENSION SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-54588 NOTIFICATION OF LATE FILING x Form 10-K o Form 11-K o Form 20-F o Form 10-Q o Form N-SAR For Period Ended: October 31, 2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR For the Transition Period Ended: Nothin |
|
| October 17, 2014 |
Exhibit 10.87 PROMISSORY NOTE U.S. $150,000.00 Newark, New Jersey October 13, 2014 FOR VALUE RECEIVED, the undersigned (hereinafter referred to as "Borrower" or "Maker") promises to pay to the order of MICHAEL FRANCIS (hereinafter referred to as "Payee" or “Lender”); Payee or Lender, together with any subsequent holders hereof, (hereinafter collectively referred to as "Holder" or “Note Holder”) at |
|
| October 17, 2014 |
Exhibit 10.86 PROMISSORY NOTE U.S. $175,000.00 Bound Brook, New Jersey October, 2014 FOR VALUE RECEIVED, the undersigned (hereinafter referred to as "Borrower" or "Maker") promises to pay to the order of JAMES R. SOLAKIAN (hereinafter referred to as "Payee" or “Lender”); Payee or Lender, together with any subsequent holders hereof, (hereinafter collectively referred to as "Holder" or “Note Holder” |
|
| October 17, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2014 BIONEUTRAL GROUP, INC. |
|
| September 22, 2014 |
BIONEUTRAL GROUP, INC. CONVERTIBLE PROMISSORY NOTE Exhibit 10.85 THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES |
|
| September 22, 2014 |
Exhibit 10.83 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SE |
|
| September 22, 2014 |
SETTLEMENT AGREEMENT AND STIPULATION Exhibit 10.78 SETTLEMENT AGREEMENT AND STIPULATION THIS SETTLEMENT AGREEMENT and Stipulation dated as of September 20, 2013 by and between ASC Recap LLC ("ASC"), a limited liability company formed under the laws of the State of Connecticut, with offices in Fairfield County, Connecticut, and Bioneutral Group, Inc., a corporation incorporated under the laws of Nevada, with offices in Newark, New Jer |
|
| September 22, 2014 |
Exhibit 10.84 NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THE |
|
| September 22, 2014 |
Exhibit 10.81 SECURITIES TRANSFER AGREEMENT This SECURITIES TRANSFER AGREEMENT (the ?Agreement?), is entered into this 21st day of June, 2014, by and among JAMES CASSERLY (hereinafter referred to as "Seller"), Darling Capital, LLC (hereinafter referred to as the "Buyer") and BioNeutral Group, Inc. a Nevada corporation (?BONU" or the "Company"). RECITALS WHEREAS, BONU is a publicly traded corporati |
|
| September 22, 2014 |
BioNeutral Group QUARTERLY REPORT (Quarterly Report) 10-Q 1 f10q0714bioneutral.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| September 22, 2014 |
BIONEUTRAL GROUP, INC. PROMISSORY NOTE DUE MAY 31, 2014 EX-10.79 3 f10q0714ex10lxxixbio.htm PROMISSORY NOTE DUE MAY 31, 2014 Exhibit 10.79 NEITHER THIS SECURITY NOR THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OR UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES ARE RESTRICTED AND MAY NOT BE OFFERED, RESOLD, PLEDGED OR T |
|
| September 22, 2014 |
15% CONVERTIBLE PROMISSORY NOTE EX-10.82 6 f10q0714ex10lxxxiibio.htm 15% CONVERTIBLE PROMISSORY NOTE Exhibit 10.82 15% CONVERTIBLE PROMISSORY NOTE THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SUCH LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS OF TRA |
|
| September 22, 2014 |
Exhibit 10.80 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SE |
|
| September 11, 2014 |
BONU / BioNeutral Group, Inc. NT 10-Q - - NOTIFICATION OF LATE FILING SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-54588 NOTIFICATION OF LATE FILING o Form 10-K o Form 11-K o Form 20-F x Form 10-Q o Form N-SAR For Period Ended: July 31, 2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR For the Transition Period Ended: Nothing i |
|
| August 18, 2014 |
BONU / BioNeutral Group, Inc. PRE 14C - - INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| August 7, 2014 |
BONU / BioNeutral Group, Inc. / DARLING CAPITAL, LLC. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. )* BioNeutral Group Inc (Name of Issuer) Common Stock (Title of Class of Securities) 090621103 (CUSIP Number) July 29, 2014 (Date of Event Which |
|
| July 23, 2014 |
BONU / BioNeutral Group, Inc. PRE 14C - - SCHEDULE 14C INFORMATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| July 1, 2014 |
BONU / BioNeutral Group, Inc. DEF 14C - - SCHEDULE 14C INFORMATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| June 20, 2014 |
Exhibit 10.70 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 26, 2014, by and between BIONEUTRAL GROUP, INC., a Nevada corporation, with headquarters located at 211 Warren Street, Newark, NJ 07103 (the “Company”), and KBM WORLDWIDE, INC., a New York corporation, with its address at 80 Cuttermill Road, Suite 410, Great Neck, NY 11021 (the “Buye |
|
| June 20, 2014 |
Exhibit 10.69 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $15,657.53 ORIGINALLY ISSUED AUG |
|
| June 20, 2014 |
EX-10.64 2 f10q0414ex10lxivbioneutral.htm SECURITIES PURCHASE AGREEMENT WITH MAGNA GROUP, LLC ON FEBRUARY 28, 2014 FOR $78,164.38. Exhibit 10.64 BIONEUTRAL GROUP, INC. $78,164.38 TWELVE PERCENT (12%) CONVERTIBLE NOTE DATED FEBRUARY 28, 2014 THIS NOTE (the "Note") is a duly authorized Convertible Note of BIONEUTRAL GROUP, INC., a(n) NEVADA corporation (the "Company"). FOR VALUE RECEIVED, the Compan |
|
| June 20, 2014 |
Exhibit 10.72 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $154,875.00 ORIGINALLY ISSUED JU |
|
| June 20, 2014 |
BIONEUTRAL GROUP, INC. 6% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 19, 2015 Exhibit 10.66 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $40,000.00 BIONEUTRAL GROUP, INC |
|
| June 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL |
|
| June 20, 2014 |
EX-10.68 6 f10q0414ex10lxviiibioneut.htm CONVERTIBLE PROMISSORY NOTE WITH GEL PROPERTIES ON MARCH 19, 2014 FOR $15,960. Exhibit 10.68 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 19 |
|
| June 20, 2014 |
BIONEUTRAL GROUP, INC. 8% CONVERTIBLE REDEEMABLE NOTE DUE APRIL 2, 2015 EX-10.71 9 f10q0414ex10lxxibioneutral.htm CONVERTIBLE PROMISSORY NOTE WITH LG CAPITAL FUNDING, LLC ON APRIL 2, 2014 FOR $35,000. Exhibit 10.71 THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROV |
|
| June 20, 2014 |
Exhibit 10.76 NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THE |
|
| June 20, 2014 |
BIONEUTRAL GROUP, INC. 8% CONVERTIBLE REDEEMABLE NOTE DUE APRIL 28, 2015 NOTE 1 Exhibit 10.74 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $38,750.00 BIONEUTRAL GROUP, INC |
|
| June 20, 2014 |
Exhibit 10.65 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| June 20, 2014 |
Exhibit 10.77 Securities Purchase Agreement This Securities Purchase Agreement (this “Agreement”), dated as of May 21, 2014, is entered into by and between BioNeutral Group, Inc., a Nevada corporation (“Company”), and Typenex Co-Investment, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”). A. Company and Investor are executing and delivering this Agreement in relia |
|
| June 20, 2014 |
Exhibit 10.73 NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THE |
|
| June 20, 2014 |
Exhibit 10.67 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $52,191.78 ORIGINALLY ISSUED AUG |
|
| June 20, 2014 |
Exhibit 10.75 PROMISSORY NOTE (this ?Note?) Principal Amount: $152,414.00 New York, New York May 12, 2014 FOR VALUE RECEIVED, BioNeutral Group, Inc., a Nevada Corporation, having an address at 211 Warren St., Newark, NJ 07103, Tel # 973-577-8003 (?Maker?) hereby promises to pay to Reed Smith LLP having an address at 599 Lexington Avenue, New York, NY 10022 (Attention: Herbert F. Kozlov) or its suc |
|
| June 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| June 16, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-54588 NOTIFICATION OF LATE FILING o Form 10-K o Form 11-K o Form 20-F x Form 10-Q o Form N-SAR For Period Ended: April 30, 2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR For the Transition Period Ended: Nothing |
|
| May 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| April 22, 2014 |
- REGISTRATION STATEMENT WITHDRAWL \ April 22, 2014 United States Securities and Exchange Commission Division of Corporate Finance Mail Stop 6010 100 F Street, N. |
|
| April 21, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| March 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the three month period ended January 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEU |
|
| February 13, 2014 |
Exhibit 10.54 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $23,600.00 BIONEUTRAL GROUP, INC |
|
| February 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL GROUP |
|
| February 13, 2014 |
EX-10.58 10 f10k2013ex10lviiibioneutral.htm CONVERTIBLE PROMISSORY NOTE WITH GEL PROPERTIES ON JANUARY 14, 2013 FOR $23,600. Exhibit 10.58 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT |
|
| February 13, 2014 |
EX-10.53 5 f10k2013ex10liiibioneutral.htm CONVERTIBLE PROMISSORY NOTE WITH GEL PROPERTIES ON DECEMBER 18, 2013 FOR $20,000. Exhibit 10.53 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT O |
|
| February 13, 2014 |
Exhibit 10.52 PROMISSORY NOTE (this “Note”) Principal Amount: $75,000.00 New York, New York As Of November 11, 2013 FOR VALUE RECEIVED, BioNeutral Group, Inc., a Nevada Corporation, having an address at BioNeutral Group, Inc. 211 Warren Street, Suite 400, Newark, NJ 07103 (“Maker”) hereby promises to pay to Herbert F. Kozlov having an address at 36 Claremont Road, Scarsdale New York, NY 10583 or h |
|
| February 13, 2014 |
Exhibit 10.57 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $30,000.00 BIONEUTRAL GROUP, INC |
|
| February 13, 2014 |
PROMISSORY NOTE $15,000 Newark, New Jersey August 19, 2013 Exhibit 10.50 NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THE |
|
| February 13, 2014 |
Exhibit 10.59 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $25,275.62 ORIGINALLY ISSUED FEB |
|
| February 13, 2014 |
Exhibit 10.63 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $44,071.23 ORIGINALLY ISSUED JUN |
|
| February 13, 2014 |
Exhibit 10.51 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| February 13, 2014 |
Exhibit 10.61 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $25,000.00 BIONEUTRAL GROUP 6% C |
|
| February 13, 2014 |
EX-10.60 12 f10k2013ex10lxbioneutral.htm CONVERTIBLE PROMISSORY NOTE ISSUED BY GEL PROPERTIES ON FEBRUARY 10, 2013 FOR $25,000. Exhibit 10.60 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRA |
|
| February 13, 2014 |
EX-10.56 8 f10k2013ex10lvibioneutral.htm CONVERTIBLE PROMISSORY NOTE WITH GEL PROPERTIES ON JANUARY 8, 2013 FOR $23,600. Exhibit 10.56 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1 |
|
| February 13, 2014 |
EX-10.62 14 f10k2013ex10lxiibioneutral.htm CONVERTIBLE PROMISSORY NOTE WITH GEL PROPERTIES ON FEBRUARY 10, 2013 FOR $25,000. Exhibit 10.62 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT |
|
| February 13, 2014 |
Exhibit 10.55 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $20,000.00 BIONEUTRAL GROUP, INC |
|
| January 30, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-54588 NOTIFICATION OF LATE FILING x Form 10-K o Form 11-K o Form 20-F o Form 10-Q o Form N-SAR For Period Ended: October 30, 2013 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR For the Transition Period Ended: Nothin |
|
| December 18, 2013 |
- PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| September 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL |
|
| September 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| August 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2013 BIONEUTRAL GROUP, INC. |
|
| August 23, 2013 |
EXHIBIT 3.4 ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIONEUTRAL GROUP, INC. CERTIFICATE OF DESIGNATIONS OF SERIES F PREFERRED STOCK The undersigned, being the President and Chief Executive Officer of BioNeutral Group, Inc., a corporation organized and existing under the laws of the State of Nevada (the “Corporation”), DOES HEREBY CERTIFY AND AMEND THE CORPORATION’S ARTICLES OF INC |
|
| August 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement BIONEUTRAL GROUP, INC. (Name of Regi |
|
| August 23, 2013 |
DEFERRED COMPENSATION AGREEMENTS – MARK LOWENTHAL; ANDY KIELBANIA; TOM CUNNINGHAM EXHIBIT 10.45 DEFERRED COMPENSATION AGREEMENTS – MARK LOWENTHAL; ANDY KIELBANIA; TOM CUNNINGHAM NEITHER THE SECURITIES REPRESENTED BY THIS AGREEMENT OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS AGREEMENT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, |
|
| August 23, 2013 |
SERIES F PREFERRED STOCK AGREEMENT Private and Confidential EXHIBIT 10.43 SERIES F PREFERRED STOCK AGREEMENT Private and Confidential THIS SERIES F PREFERRED STOCK AGREEMENT (the “Agreement”), made as of the last date executed below (the “Effective Date”), by and among BioNeutral Group, Inc. a Nevada corporation with a principal address of 211 Warren Street, Newark, NJ 07103 (“the “Company”), and Mark Lowenthal, an individual with an address of c/o , 211 W |
|
| August 23, 2013 |
PROMISSORY NOTE MODIFICATION AGREEMENT – MICHAEL FRANCIS EXHIBIT 10.44 PROMISSORY NOTE MODIFICATION AGREEMENT – MICHAEL FRANCIS NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFE |
|
| June 24, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL GROUP, IN |
|
| June 24, 2013 |
Note Satisfaction and Exchange Agreement EX-10.42 2 f10q0413ex10xxxxiibioneutr.htm NOTE SATISFACTION AND EXCHANGE AGREEMENT BETWEEN THE COMPANY AND HERB KOZLOV Exhibit 10.42 Note Satisfaction and Exchange Agreement Whereas, BioNeutral Group, Inc. (together with its subsidiaries, "BioN") is indebted to Herbert F. Kozlov ("Creditor") in the sum of $50,000.00 plus accrued interest of $10,750.00 (accrued through May 31, 2012) pursuant to the |
|
| June 17, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-54588 NOTIFICATION OF LATE FILING o Form 10-K o Form 11-K o Form 20-F x Form 10-Q o Form N-SAR For Period Ended: April 30, 2013 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR For the Transition Period Ended: Nothing |
|
| May 21, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2013 BIONEUTRAL GROUP, INC. |
|
| May 21, 2013 |
Exhibit 99.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| April 18, 2013 |
BioNeutral terminates relationship with Vinfluence. EX-99.3 4 f8k041213ex99iiibioneutral.htm PRESS RELEASE DATED APRIL 18, 2013 Exhibit 99.3 BioNeutral terminates relationship with Vinfluence. NEWARK, N.J., April 18, 2013 -/PR Newswire/- BioNeutral Group, Inc. (OTCBB: BONU) Mark Lowenthal, President and CEO of BioNeutral Group, Inc, a specialty life science technology based company announced today the termination of their relationship with Vinfluen |
|
| April 18, 2013 |
EX-99.1 2 f8k041213ex99ibioneutral.htm GLOBAL RELEASE, CANCELLATION OF PREFERRED STOCK PURCHASE AGREEMENT, PREFERRED STOCK DRAWDOWN AGREEMENT, THE AGREEMENT TO ASSIGN AND SETTLE NOTES AND AGREEMENT TO LICENSE INVENTION AGREEMENT BY AND BETWEEN THE COMPANY AND VINFLUENCE PTY LTD. DATED APRIL 12 Exhibit 99.1 SETTLEMENT AGREEMENT, GLOBAL RELEASE AND CANCELATION OF PREFERRED STOCK PURCHASE AGREEMENT, |
|
| April 18, 2013 |
8-K 1 f8k041213bioneutral.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2013 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other ju |
|
| April 18, 2013 |
Exhibit 99.2 DISTRIBUTORSHIP AGREEMENT This Distribution Agreement (the "Agreement") is made this day of April, 2013 (the "Effective Date") by and between BioNeutral Group, Inc., a Nevada corporation (the "Supplier"), whose registered office is at 55 Madison Avenue, Suite 400, Morristown, New Jersey 07960, and White Charger Limited, a New Zealand limited company (the "Distributor"), whose register |
|
| March 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the three month period ended January 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEU |
|
| March 5, 2013 |
BioNeutral Group, Inc. 55 Madison Avenue, Suite 400, Morristown, NJ 07960 March 5, 2013 Ms. Pamela Long Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20542 Re: BioNeutral Group, Inc. Registration Statement on Form S-1 (Reg. No. 333-186772) Dear Ms. Long: On behalf of BioNeutral Group, Inc. (the "Company"), the following language is hereby added to the Company's Registrat |
|
| March 5, 2013 |
BioNeutral gains initial market acceptance. Exhibit 99.2 BioNeutral gains initial market acceptance. NEWARK, N.J., Feb. 22, 2013 -/PR Newswire/- BioNeutral Group, Inc. (OTCBB: BONU) Mark Lowenthal, President and CEO of BioNeutral Group, Inc, a specialty life science technology based company announced today that following an extensive product development and testing period, the initial reception of its products in the marketplace has far exc |
|
| March 5, 2013 |
Principal Amount: $42,500.00 Issue Date: February 25, 2013 Purchase Price: $42,500.00 EX-99.1 2 f8k030513ex99ibioneutral.htm PROMISSORY NOTE DATED FEBRUARY 25, 2013 IN FAVOR OF ASHER ENTERPRISES INC. Exhibit 99.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE |
|
| March 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2013 BIONEUTRAL GROUP, INC. |
|
| March 5, 2013 |
Exhibit 99.3 Dear Stockholder, As many of you know, I joined the Company mid last year, and this is the first time I'm taking the opportunity to update you on the Company’s progress. As you may know, in the fall of 2012, we announced the successful testing of our Ygiene™ 206 product at Barnabas Health, and then again by the Battelle Institute at the Army's Aberdeen Proving Grounds. Following that, |
|
| February 21, 2013 |
Registration Statement - REGISTRATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 26-0745273 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 55 Madison Avenue, Suite 400, Morristown, New Jersey 07960 (Address |
|
| January 29, 2013 |
10-K 1 f10k2012bioneutral.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Com |
|
| December 14, 2012 |
PROMISSORY NOTE $409,252 New York, New York December 6, 2012 Exhibit 99.2 NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THER |
|
| December 14, 2012 |
EX-99.4 5 f8k120712ex99ivbioneutral.htm EQUITY PURCHASE AGREEMENT DATED DECEMBER 11, 2012 BY AND BETWEEN THE COMPANY AND SOUTHRIDGE PARTNERS II, LP Exhibit 99.4 EQUITY PURCHASE AGREEMENT BY AND BETWEEN BIONEUTRAL GROUP, INC. AND SOUTHRIDGE PARTNERS II, LP Dated December , 2012 THIS EQUITY PURCHASE AGREEMENT entered into as of the day of December, 2012 (this "AGREEMENT"), by and between SOUTHRIDGE |
|
| December 14, 2012 |
BIONEUTRAL GROUP, INC. PROMISSORY NOTE DUE MAY 31, 2013 Exhibit 99.3 NEITHER THIS SECURITY NOR THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OR UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES ARE RESTRICTED AND MAY NOT BE OFFERED, RESOLD, PLEDGED OR TRANSFERRED EXCEPT AS PERMITTED UNDER THE ACT PURSUANT TO REGISTRATION |
|
| December 14, 2012 |
BONU Interest free if paid in full within 3 months Exhibit 99.1 BONU Interest free if paid in full within 3 months $250,000 PROMISSORY NOTE FOR VALUE RECEIVED, Bioneutral Group, Inc., a Nevada corporation (the “Borrower”) with at least 125,000,000 common shares issued and outstanding, promises to pay to JMJ Financial or its Assignees (the “Lender”) the Principal Sum along with the Interest Rate and any other fees according to the terms herein. Thi |
|
| December 14, 2012 |
8-K 1 f8k120712bioneutral.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2012 (December 7, 2012 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-07452 |
|
| November 16, 2012 |
8-K 1 f8k103112bioneutral.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2012 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other |
|
| November 16, 2012 |
SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 31, 2012, by and between BIONEUTRAL GROUP, INC. |
|
| November 16, 2012 |
EX-99.2 3 v328789ex99-2.htm NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION |
|
| November 8, 2012 |
As filed with the Securities and Exchange Commission on November 7, 2012 Registration No. |
|
| November 8, 2012 |
BIONEUTRAL GROUP, INC. 2012 PROFESSIONAL/CONSULTANT STOCK COMPENSATION PLAN Exhibit 10.1 BIONEUTRAL GROUP, INC. 2012 PROFESSIONAL/CONSULTANT STOCK COMPENSATION PLAN 1. Purpose. The purpose of this Plan is to provide compensation in the form of Common Stock of BioNeutral Group, Inc. (the “Corporation”), to eligible consultants that have previously rendered services or that will render services during the term of this 2012 Professional/Consultant Stock Compensation Plan (th |
|
| October 12, 2012 |
EX-99.1 2 f8k100312ex99ibioneutral.htm SECURITIES PURCHASE AGREEMENT Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of September 20, 2012, by and between BIONEUTRAL GROUP, INC., a Nevada corporation, with headquarters located at 55 Madison Avenue, Morristown NJ 07960 (the "Company"), and ASHER ENTERPRISES, INC., a Delaware corporation, wit |
|
| October 12, 2012 |
Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| October 12, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2012 BIONEUTRAL GROUP, INC. |
|
| October 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2012 BIONEUTRAL GROUP, INC. |
|
| October 3, 2012 |
EX-99.1 2 f8k100312ex99ibioneutral.htm PRESS RELEASE ISSUED BY THE COMPANY ON OCTOBER 2, 2012. Exhibit 99.1 Final St Barnabas Press Release Ygiene 206 Sterilant May be Effective At Removing Some Health Threatening Microorganisms In the Presence of Blood From Certain Contaminated Surgical Instruments Morristown, NJ, October 2,, 2012 — BioNeutral Group Inc. (OTC Bulletin Board: BONU- News), a specia |
|
| October 3, 2012 |
EX-99.2 3 f8k100312ex99iibioneutral.htm WHITE PAPER Exhibit 99.2 APPROVED FOR RELEASE 9/28/12 The Use of Ygiene 206 as a Possible Bloodborne Pathogen Exposure Strategy for Healthcare Workers Nancy Chobin, RN, AAS, ACSP, CSPDM ABSTRACT: Exposures to blood and/or body fluids from used surgical instruments continues to occur on a daily basis. Other than engineering and work practice controls, there i |
|
| October 3, 2012 |
Financial Statements and Exhibits 8-K 1 f8k100312bioneutral.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2012 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other j |
|
| September 14, 2012 |
PROMISSORY NOTE $100,000 New York, New York August 8, 2012 Exhibit 10.28 NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THE |
|
| September 14, 2012 |
PROMISSORY NOTE $60,000 New York, New York June 7, 2012 Exhibit 10.27 NEITHER THE SECURITIES REPRESENTED BY THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THE |
|
| September 14, 2012 |
Exhibit 10.29 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| September 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL |
|
| July 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 BIONEUTRAL GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 26-0745273 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 55 Madison Avenue, Suit |
|
| July 30, 2012 |
Exhibit 3.4 CORPORATE CHARTER I, ROSS MILLER, the duly elected and qualified Nevada Secretary of State, do hereby certify that BIONEUTRAL GROUP, INC., did on April 10, 2007, file in this office the original Articles of Incorporation; that said Articles of Incorporation are now on file and of record in the office of the Secretary of State of the State of Nevada, and further, that said Articles cont |
|
| July 9, 2012 |
BioNeutral Group Appoints Mr. Mark Lowenthal as Chief Executive and President Exhibit 99.1 BioNeutral Group Appoints Mr. Mark Lowenthal as Chief Executive and President NEWARK, NJ, July 9, 2012 — BioNeutral Group Inc, (OTC Bulletin Board: BONU - News), a specialty life science technology-based company, today announced that Mr. Mark Lowenthal has agreed to serve as BioNeutral’s President and Chief Executive Officer, effective July 2, 2012. Mr. Lowenthal currently serves as a |
|
| July 9, 2012 |
Exhibit 10.1 Employment Agreement This EMPLOYMENT AGREEMENT (this “Agreement”), is made effective as of the 2nd day of July, 2012, (the “Effective Date”) by and between Bioneutral Group, Inc., a Nevada corporation, with an address at 55 Madison Avenue, Suite 400, Morristown, New Jersey, 07960 (the “Company”) and Mr. Mark Lowenthal, an individual with an address at 311 Walnut Street, Englewood, New |
|
| July 9, 2012 |
Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2012 (July 2nd, 2012) BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporation) |
|
| June 29, 2012 |
Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2012 (June 27, 2012) BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporation) |
|
| June 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL |
|
| April 25, 2012 |
Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2012 (April 24, 2012) BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporatio |
|
| March 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the three month period ended January 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEU |
|
| March 8, 2012 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2012 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 5, 2012 |
Exhibit 99.1 For Immediate Release Contact: March 5, 2012 BIONEUTRAL GROUP PARTNERS WITH DLA PIPER AND SENATOR TOM DASCHLE MORRISTOWN, NJ: March 5, 2012: BioNeutral Group (OTC: BONU) announced that it has entered into an agreement with DLA Piper, a leading global law firm, for DLA Piper to assist BioNeutral Group by providing strategic advice and assisting the company in securing government and mi |
|
| March 5, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 f8k030212bioneutral.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2012 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdi |
|
| February 10, 2012 |
10-K 1 f10k2011bioneutral.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Comm |
|
| February 10, 2012 |
EX-10.22 3 f10k2011ex10xxiibioneutral.htm INDEMNIFICATION AGREEMENT - RON DEL MAURO Exhibit 10.22 INDEMINIFCATION AGREEMENT THIS INDEMINIFICATION AGREEMENT (this “Agreement”) is entered into on October 29, 2011 by and among BioNeutral Group, Inc. a Nevada corporation (the “Company”) and the Indemnitee (“Indemnitee”) executing this Agreement. RECITALS WHEREAS, it is essential to the Company that it |
|
| February 10, 2012 |
Agreement For Appointment To Board of Directors Exhibit 10.21 Agreement For Appointment To Board of Directors 1. PARTIES: a. Ronald J. DelMauro ("RD") and b. BioNeutral Group, Inc., a Nevada Corporation ("BioN”or the "Company"). 2. Relationship Formed, Duties and Responsibilities: RD will become a member of the BioN Board of Directors the ("Board"), effective upon his election to the Board of Directors. RD will serve on or chair committees of t |
|
| January 31, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): þForm 10-K o Form 20-F o Form 11-K oForm 10-Q oForm 10-I o Form NSAR o Form N-CSR For Period Ended: October 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on For |
|
| January 25, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2012 (January 18, 2012) BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorpor |
|
| January 25, 2012 |
Exhibit 10.1 COLLABORATION AGREEMENT This Collaboration Agreement is entered into among and between: BioNeutral Group Inc. (together with BioNeutral Laboratories Corporation USA and their affiliates, “BONU” or the “company”); AND Saint Barnabas Corporation, trading as Barnabas Health (hereinafter, “BH”) is a not for profit corporation organized under the laws of the State of New Jersey Whereas, BO |
|
| January 25, 2012 |
BIONEUTRAL AND BARNABAS HEALTH TO COLLABORATE FOR SURGICAL INSTRUMENT STERILIZATION Exhibit 99.1 For Immediate Release Contact: January 24, 2012 BIONEUTRAL AND BARNABAS HEALTH TO COLLABORATE FOR SURGICAL INSTRUMENT STERILIZATION MORRISTOWN, NJ: January 24, 2012: BioNeutral Group, Inc. (OTCBB: BONU), and Barnabas Health in West Orange, New Jersey, jointly announced today a collaborative research and revenue sharing agreement. The parties will develop protocols to trial Ygiene 206, |
|
| November 8, 2011 |
EX-10.8 9 f8k103111ex10viiibioneutral.htm EMPLOYMENT AGREEMENT BETWEEN BIONEUTRAL GROUP, INC. AND DR. KIELBANIA?S Exhibit 10.8 Employment Agreement This EMPLOYMENT AGREEMENT (this “Agreement”), is made effective as of the [] day of [], 2011, (the “Effective Date”) by and between Bioneutral Group, Inc., a Nevada corporation, with an address at 211 Warren Street, Newark, New Jersey, 07103 (the “Comp |
|
| November 8, 2011 |
PREFERRED STOCK PURCHASE AGREEMENT EX-10.1 2 f8k103111ex10ibioneutral.htm PREFERRED STOCK PURCHASE AGREEMENT Exhibit 10.1 PREFERRED STOCK PURCHASE AGREEMENT THIS PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of November 7, 2011 by and between BioNeutral Group, Inc., a Nevada corporation (the “Company”), and Vinfluence Pty Ltd ACN 147 137 899 (“Purchaser”). RECITALS WHEREAS, pursuant to that certain Subscription A |
|
| November 8, 2011 |
PREFERRED STOCK DRAWDOWN AGREEMENT Exhibit 10.4 PREFERRED STOCK DRAWDOWN AGREEMENT THIS PREFERRED STOCK DRAWDOWN AGREEMENT (this “Agreement”) is made as of November 7, 2011 by and between BioNeutral Group, Inc., a Nevada corporation (the “Company”), and Vinfluence Pty Ltd ACN 147 137 899 (“Purchaser”). RECITALS WHEREAS, the Company desires to sell to Purchaser and Purchaser desires to purchase from the Company the number of shares |
|
| November 8, 2011 |
Agreement to Assign and Settle Debt Exhibit 10.2 Agreement to Assign and Settle Debt Whereas, BioNeutral Group Inc. (“BioN”) is indebted to numerous creditors; and Whereas, BioN has concluded that as a consequence of BioN’s current financial condition BioN is not likely to be able to repay to its creditors the amounts owed to the creditors; and Whereas, Vinfluence Pty Ltd, (“VPL”) is attempting to assist BioN in restructuring BioN a |
|
| November 8, 2011 |
Agreement FOR APPOINTMENT OF CHAIRMAN Exhibit 10.7 Agreement FOR APPOINTMENT OF CHAIRMAN 1. PARTIES: a. Frank Battafarano ("FB") and b. BioNeutral Group, Inc., a Nevada corporation ("BioN") 2. Relationship Formed, Duties and Responsibilities: FB will become a member of the BioN Board of Dirctors and Chairman of the board of directors of BioN, effective immediately. As Chairman, FB will chair the BioN board; act as liaison between the |
|
| November 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2011 (November 1, 2011) BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorpor |
|
| November 8, 2011 |
Exhibit 10.5 Parties Bioneutral Group, Inc, a corporation organized under the laws of Nevada, with an executive office at 211 Warren Street, Newark, New Jersey 07103, Attn: Raj Pamani Bioneutral Laboratories Corporation USA a corporation organized under the laws of Delaware, 211 Warren Street, Newark, New Jersey 07103, Attn: Raj Pamani ? together referred to as BONU And Vinfluence Pty Ltd ACN 147 |
|
| November 8, 2011 |
FORM OF INDEMINIFCATION AGREEMENT Exhibit 10.6 FORM OF INDEMINIFCATION AGREEMENT THIS INDEMINIFICATION AGREEMENT (this "Agreement") is entered into on November 3, 2011by and among BioNeutral Group, Inc., a Nevada corporation (the " Company") and the Indemnitee ("Indemnitee") executing this Agreement. RECITALS WHEREAS, it is essential to the Company that it be able to retain and attract as directors the most capable persons availab |
|
| November 8, 2011 |
Agreement to Assign and Settle Notes Exhibit 10.3 Agreement to Assign and Settle Notes Whereas, BioNeutral Group Inc. (?BioN?) is indebted to numerous note holders; and Whereas, BioN has concluded that as a consequence of BioN?s current financial condition BioN is not likely to be able to repay to its note holders the amounts owed to the note holders; and Whereas, Vinfluence Pty Ltd, (?VPL?) is attempting to assist BioN in restructur |
|
| October 17, 2011 |
SC 13G/A 1 francissc13ga1.htm AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 BioNeutral Group, Inc. (Name of Issuer) Common Stock, par value $.00001 per share (Title of Class of Securities) 090621103 (CUSIP Number) August 27, 2009 (Date of Event Which Requires Filing of this Statement) |
|
| September 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL |
|
| July 12, 2011 |
BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 July 8, 2011 VIA EDGAR AND FACSIMILE Andrew D. Mew United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: BioNeutral Group, Inc. Form 10-K for the Fiscal Year Ended October 31, 2010 Filed February 15, 2011 Form 10-Q for the Fiscal Quarter Ended April 30, 2011 Fi |
|
| June 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-149235 BIONEUTR |
|
| June 14, 2011 |
BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 June 13, 2011 VIA EDGAR AND FACSIMILE Andrew D. Mew United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: BioNeutral Group, Inc. Form 10-K for the Fiscal Year Ended October 31, 2010 Filed February 15, 2011 File No. 333-149235 Dear Mr. Mew: We acknowledge receip |
|
| June 3, 2011 |
BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 June 3, 2011 VIA EDGAR AND FACSIMILE Andrew D. Mew United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: BioNeutral Group, Inc. Form 10-K for the Fiscal Year Ended October 31, 2010 Filed February 15, 2011 File No. 333-149235 Dear Mr. Mew: We acknowledge receipt |
|
| April 22, 2011 |
BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 April 22, 2011 VIA EDGAR AND FACSIMILE Andrew D. Mew United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: BioNeutral Group, Inc. Form 10-K for the Fiscal Year Ended October 31, 2010 Filed February 15, 2011 File No. 333-149235 Dear Mr. New: We acknowledge recei |
|
| April 13, 2011 |
BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 BIONEUTRAL GROUP, INC. 211 Warren Street Newark, New Jersey 07103 April 12, 2011 VIA EDGAR Andrew D. Mew United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: BioNeutral Group, Inc. Form 10-K for the Fiscal Year Ended October 31, 2010 Filed February 15, 2011 File No. 333-149235 Dear Mr. Mew: We acknowledge receipt of the lett |
|
| April 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2011 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 25, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2011 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-149235 BIONEU |
|
| March 18, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-149235 CUSIP NUMBER 090621103 NOTIFICATION OF LATE FILING (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10D o Form N-SAR o Form N-CSR For Period Ended: January 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tran |
|
| February 28, 2011 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2011 BIONEUTRAL GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 333-149235 26-0745273 (State or Other Jurisdiction (Commission (IRS Employer of |
|
| February 28, 2011 |
Exhibit 99.1 BioNeutral Group Achieves EPA Approval for Its YgieneTM Disinfectant BioNeutral announces receipt of US regulatory approval for its hospital and industrial grade line of antimicrobial products NEWARK, NJ, Feburary 28, 2011 — BioNeutral Group, Inc. (OTC Bulletin Board: BONU - News), a specialty life science technology-based company, today announced that it has received approval and reg |
|
| February 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2010. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL GROU |
|
| February 15, 2011 |
EX-4.12 2 f10k2010ex4xiibioneutral.htm 8% EXCHANGEABLE PROMISSORY NOTE, DATED AUGUST 31, 2010, ISSUED IN FAVOR OF CAPARA INVESTMENTS LLC Exhibit 4.12 NEITHER THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES ISSUABLE UPON EXCHANGE OF THIS PROMISSORY NOTE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS |
|
| February 15, 2011 |
Exhibit 4.14 THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TR ANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR AN OPINION OF COUNSEL, |
|
| February 15, 2011 |
Exhibit 4.13 NEITHER THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES ISSUABLE UPON EXCHANGE OF THIS PROMISSORY NOTE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE AND THE SECURITIES ISSUABLE UPON EXCHANGE OF THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED O |
|
| February 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-149235 CUSIP NUMBER 090621103 NOTIFICATION OF LATE FILING (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10D o Form N-SAR o Form N-CSR For Period Ended: October 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tran |
|
| January 14, 2011 |
8-K 1 f8k011411bioneutral.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2011 BIONEUTRAL GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 333-149235 26-0745273 (State or Othe |
|
| December 3, 2010 |
BioNeutral Group Elects Dr. Andy Kielbania, Chief Science Officer, to Board of Directors Exhibit 99.1 BioNeutral Group Elects Dr. Andy Kielbania, Chief Science Officer, to Board of Directors NEWARK, NJ, December 3, 2010 ? BioNeutral Group Inc, (OTC Bulletin Board: BONU - News), a specialty life science technology-based company, today announced that Dr. Andy Kielbania, BioNeutral Group?s Chief Scientist, has been elected to BioNeutral?s Board of Directors, effective November 30, 2010. |
|
| December 3, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 30, 2010 BIONEUTRAL GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 333-149235 26-0745273 (State or Other Jurisdiction (Commission File Number) (IRS |
|
| September 20, 2010 |
EX-4.1 2 f10q0710ex4ibioneutral.htm 8% EXCHANGEABLE PROMISSORY NOTE, DATED APRIL 30, 2010 Exhibit 4.1 EXECUTION COPY NEITHER THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES ISSUABLE UPON EXCHANGE OF THIS PROMISSORY NOTE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE AND THE SE |
|
| September 20, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL |
|
| September 20, 2010 |
EX-10.1 2 f8k092010ex99ibioneutral.htm PRESS RELEASE Exhibit 99.1 BioNeutral Group Inc. Announces Financial Results for the Third Quarter of 2010 Company Achieves Initial Revenue Related to Sales of Ogiene™ and Submits Application to the U.S. Environmental Protection Agency for Ygiene™ NEWARK, N.J., September 20, 2010 - BioNeutral Group Inc., (OTCBB:)BONU, a specialty chemical technology-based lif |
|
| September 20, 2010 |
8% EXCHANGEABLE PROMISSORY NOTE US$25,000.00 Newark, NJ No.: 7 As of July 7, 2010 EX-4.2 3 f10q0710ex4iiibioneutral.htm 8% EXCHANGEABLE PROMISSORY NOTE, DATED JULY 7, 2010 Exhibit 4.2 THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGIS |
|
| September 20, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2010 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporation) (Commissio |
|
| September 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-149235 CUSIP NUMBER 090621103 (Check one): o Form 10-K o Form 20-F o Form 11-K þ Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: July 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transi |
|
| September 2, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2010 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 333-149235 26-0745273 (State or other jurisdiction of incorporation) (Commission |
|
| August 19, 2010 |
Exhibit 99.1 BioNeutral Group Submits ?Ygiene? -206? Registration to the EPA EPA to Conduct Registration Review for use of Ygiene? as a Hospital Grade Disinfectant. Newark, NJ, August 19, 2010-BioNeutral Group, Inc. (OTCBB:BONU), a specialty chemical technology-based life science company reported that it has completed all Good Laboratory Practices testing required to support its application to the |
|
| August 19, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2010 BIONEUTRAL GROUP, INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-149235 (Commission File Number) 2 |
|
| June 29, 2010 |
As filed with the Securities and Exchange Commission on June 29, 2010 Registration No. |
|
| June 18, 2010 |
Exhibit 16.1 June 18, 2010 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of Item 4.01 of Form 8-K/A filed by Bioneutral Group, Inc. on June 18, 2010. We agree with the statements made in that item insofar as they relate to our Firm. Very truly yours, /s/ BARTOLOMEI PUCCIARELLI, LLC Bartolomei Pucciarelli, LLC |
|
| June 18, 2010 |
June 18, 2010 Lisa Sellars US Securities & Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| June 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A Current Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2010 BIONEUTRAL GROUP, INC. |
|
| June 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL |
|
| June 14, 2010 |
Exhibit 4.2 THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR AN OPINION OF COUNSEL, I |
|
| June 14, 2010 |
8% EXCHANGEABLE PROMISSORY NOTE US$250,000.00 No.: 4 Roseland, NJ As of March 15, 2010 Exhibit 4.1 THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR AN OPINION OF COUNSEL, I |
|
| June 10, 2010 |
Exhibit 16.1 June 10, 2010 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of Item 4.01 of Form 8-K for the events that occurred on June 4, 2010 to be filed by Bioneutral Group, Inc. We agree with the statements made in that item insofar as they relate to our Firm. Very truly yours, /s/ BARTOLOMEI PUCCIARELLI, LLC Bartolomei Pucciarell |
|
| June 10, 2010 |
Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2010 BIONEUTRAL GROUP, INC. |
|
| March 22, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTR |
|
| March 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-149235 CUSIP NUMBER 090621103 (Check one): o Form 10-K o Form 20-F o Form 11-K þ Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: January 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tra |
|
| March 17, 2010 |
Exhibit 10.2 Consulting Agreement I, Raj Pamani accept the position of contractor of Bioneutral Laboratories Corporation USA (the "Company"). I will accept responsibilities and take direction from the Company's Board of Directors. I accept this position as of June 15, 2008 as a contractor for total monthly compensation of $10,000 and a one time stock issuance of 4,250,000 shares of the Company's c |
|
| March 17, 2010 |
Exhibit 10.12 This Consulting Agreement (the "Agreement") is entered into on November 12th 2008 by and between RK and Associates , a corporation , ("Consultant") and BioNeutral Laboratories Corporation USA (the "Company"). RECITALS WHEREAS, the Company is in need of assistance in the Environmental Engineering support area; and WHEREAS, Consultant has agreed to perform consulting work for the Compa |
|
| March 17, 2010 |
Exhibit 10.10 LEASE THIS LEASE AGREEMENT, made this 1st day of September, 2009 between ENTERPRISE DEVELOPMENT CENTER, at the New Jersey Institute of Technology, having an office at 211 Warren Street, Newark, New Jersey, 07103 (hereinafter referred to as the "Landlord"), and BioNeutral Group, Inc a Nevada corporation having an office at 211 Warren Street, Newark, NJ 07103, hereinafter referred to a |
|
| March 17, 2010 |
Exhibit 10.14 This Consulting Agreement (the "Agreement") is entered into on September 15 th 2008 by and between Pamani Group , a corporation , Angel's Assets Holdings Ltd together referred to as (the "Consultants") and BioNeutral Laboratories Corporation USA (the "Company"). RECITALS WHEREAS, the Company was in need of assistance in the human resource, regulatory, business development, business p |
|
| March 17, 2010 |
Exhibit 10.15 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this "Agreement") is entered into on February 10, 2009, by and among BioNeutral Group, Inc., a Nevada corporation (the " Company ") and the indemnitee (" Indemnitee ") executing this Agreement. RECITALS WHEREAS, it is essential to the Company that it be able to retain and attract as directors the most capable persons available |
|
| March 17, 2010 |
Exhibit 21.1 BioNeutral Group, Inc. List of Subsidiaries Jurisdiction of Name of Subsidiary Incorporation BioNeutral Laboratories Corporation USA Delaware Environmental Commercial Technology Corporation Delaware |
|
| March 17, 2010 |
Exhibit 4.1 |
|
| March 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2009. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 333-149235 BIONEUTRAL GROU |
|
| March 17, 2010 |
Exhibit 10.11 CONSULTING AGREEMENT This agreement is entered into between Bioneutral Laboratories Corporation USA, (Bioneutral) a company incorporated under the laws of Delaware with offices in New Jersey and Jina Partners DBA, Jina Ventures LLC a company incorporated under the laws of India and with offices in Mumbai, hereafter referred to as the Consultant. Bioneutral is a Life Science company w |
|
| March 17, 2010 |
8% EXCHANGEABLE PROMISSORY NOTE Exhibit 4.8 THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR AN OPINION OF COUNSEL, I |
|
| March 17, 2010 |
EX-10.13 8 f10k2009ex10xvibioneutral.htm CONSULTANT AGREEMENT - ANDREW KIELBANIA Exhibit 10.13 Consulting Agreement I, Andrew Kielbania, accept the position of Chief Scientist of Bioneutral Laboratories Corporation USA (the “Company”). I will accept responsibilities and take direction from the Company’s Board of Directors. I accept this position as of January 1, 2008 as a contractor for total mont |
|
| February 18, 2010 |
Exhibit 10.1 First Amendment to the Advisory Agreement by and Between Chertoff Group, L.L.C. and BioNeutral Group, Inc. This First Amendment to the Advisory Agreement dated 26 August 2009 (the “Amendment”), dated this 3rd day of February 2010 (the “Amendment Effective Date”), by and between Chertoff Group, L.L.C. (“Advisor”), a Delaware limited liability company, and BIONEUTRAL GROUP, INC. (the “C |
|
| February 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 3, 2010 BIONEUTRAL GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 333-149235 26-0745273 (State or Other Jurisdiction (Commission File Number) (IRS |
|
| February 18, 2010 |
EX-4.3 4 f8k020310ex4iiibioneutral.htm 8% EXCHANGEABLE PROMISSORY NOTE - MICHAEL D. FRANCIS Exhibit 4.3 EXECUTION COPY THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF A |
|
| February 18, 2010 |
BIONEUTRAL GROUP, INC. STOCK APPRECIATION RIGHTS AGREEMENT Exhibit 10.2 BIONEUTRAL GROUP, INC. STOCK APPRECIATION RIGHTS AGREEMENT THIS STOCK APPRECIATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the 3rd day of February, 2010, by and between BioNeutral Group, Inc., a Nevada corporation (the “Company”), and Chertoff Group, L.L.C., a Delaware limited liability company (the “Grantee”). WHEREAS, this Agreement evidences an equity award the Co |
|
| February 18, 2010 |
BIONEUTRAL GROUP, INC. RESTRICTED STOCK UNIT AGREEMENT EX-10.3 7 f8k020310ex10iiibioneutral.htm RESTRICTED STOCK UNIT AGREEMENT Exhibit 10.3 BIONEUTRAL GROUP, INC. RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”) is entered into as of the 3rd day of February, 2010, by and between BioNeutral Group, Inc., a Nevada corporation (the “Company”), and Chertoff Group, L.L.C., a Delaware limited liability company (the “Gr |
|
| February 18, 2010 |
8% EXCHANGEABLE PROMISSORY NOTE EX-4.2 3 f8k020310ex4iibioneutral.htm 8% EXCHANGEABLE PROMISSORY NOTE - CAPARA INVESTMENTS LLC Exhibit 4.2 EXECUTION COPY THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE O |
|
| February 18, 2010 |
BIONEUTRAL GROUP, INC. REGISTRATION AGREEMENT February 3, 2010 TABLE OF CONTENTS Exihibit 10.4 BIONEUTRAL GROUP, INC. REGISTRATION AGREEMENT February 3, 2010 TABLE OF CONTENTS Page Section 1. Definitions 1 Section 2. Required Registrations 5 Section 3. Incidental Registration. 8 Section 4. Holdback Agreements. 9 Section 5. Registration Procedures. 10 Section 6. Registration Expenses. 13 Section 7. Indemnification and Contribution. 14 Section 8. Underwritten Registrations. 16 S |
|
| February 18, 2010 |
8% EXCHANGEABLE PROMISSORY NOTE Exhibit 4.1 EXECUTION COPY THE PROMISSORY NOTE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR APPLICABLE STATE SECURITIES LAWS. THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR AN OPINIO |
|
| February 1, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 12, 2009 BIONEUTRAL GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 333-149235 26-0745273 (State or Other Jurisdiction (Commission File Number) (IRS |
|
| January 29, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-149235 CUSIP NUMBER 090621103 (Check one): ? Form 10-K o Form 20-F o Form 11-K ? Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: October 31, 2009 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tra |
|
| September 21, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2009 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-149235 BIONEUTRAL GROUP, INC. |
|
| September 14, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-149235 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: July 31, 2009 o Transition Report |
|
| September 8, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 BioNeutral Group, Inc. (Name of Issuer) Common Stock, par value $.00001 per share (Title of Class of Securities) 090621103 (CUSIP Number) August 27, 2009 (Date of Event Which Requires Filing of this Statement) Check the following box to designate the rule pursuant to which |
|
| September 4, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 26, 2009 BioNeutral Group, Inc. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 333-149235 26-0745273 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION) ( |
|
| September 4, 2009 |
Exhibit 99.1 BioNeutral and the Chertoff Group Announce a Collaborative Agreement to Continue Development of BioNeutral's Antimicrobial and Sterilant Technologies · Press Release · Source: BioNeutral Group, Inc. · On Monday August 31, 2009, 8:29 am EDT NEWARK, N.J.-(BUSINESS WIRE)-BioNeutral Group, Inc. (OTCBB: BONU - News) has expanded its relationship with the Chertoff Group (Washington, DC). Be |
|
| September 4, 2009 |
ADVISORY AGREEMENT This Advisory Agreement (this “Agreement”), dated this day of August 2009 (the “Effective Date”), by and between Chertoff Group, L. |
|
| June 24, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the transition period from to Commission file number 333-153920 BIONEUTRAL GROUP, INC |
|
| June 24, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K o ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended x TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period for the fiscal year ended October 31, 2008 (due to the change in fiscal year) Commission File No. 33 |
|
| June 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2009 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-149235 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K X Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: APRIL 30, 2009 o Tr |
|
| March 23, 2009 |
Exhibit 10.1 March 20, 2009 BioNeutral Group Inc. 211 Warren Street Newark, NJ 07103 Re: LETTER OF INTENT To Whom It May Concern: The purpose of this Letter of Intent (?Letter?) is to set forth certain non-binding understandings and certain binding commitments betweenBioNeutral Group Inc. of 211 Warren Street, Newark, NJ 07103 (?Buyer?), of certain assets which are currently owned by Orient Arts I |
|
| March 23, 2009 |
PROFESSIONAL SERVICES AGREEMENT Exhibit 10.2 PROFESSIONAL SERVICES AGREEMENT This Agreement is made between BioNeutral Group, Inc. and Dorothy Canter Consulting, LLC (?Consultant?). 1. Services to be Performed Consultant agrees to review information provided by Client and provide expert advice regarding environmental and/or homeland security concerns of Client. 2. Payment In consideration for the services to be performed by Cons |
|
| March 23, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the transition period from to Commission file number 333-153920 BIONEUTRAL GROUP, I |
|
| March 23, 2009 |
Exhibit 10.3 Consulting Agreement This consulting agreement (the “Agreement”), entered into on March 13, 2009 and effective as of the Effective Date (as defined in Section 1(e)), is made by and between BioNeutral Group, Inc., a Nevada corporation (together with any successor thereto, the “Company”), and James Crane, an independent provider of services (the “Contractor”). RECITALS A. The Company de |
|
| March 17, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: June 30, 2011 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-149235 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: JANUARY 31, 2009 o T |
|
| February 23, 2009 |
Exhibit 16.1 Webb & Company, P.A. Certified Public Accountants February 20, 2009 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 RE: BioNeutral Group. Inc. (f/k/a Moonshine Creations. Inc.) File Ref. No. 333-149235 We have read the statements of BioNeutral Group, Inc. (f/k/a Moonshine Creations, Inc.) pertaining to our firm included under hem 4.01 of Form 8-K/A dated Fe |
|
| February 23, 2009 |
Exhibit 2.1 SHARE EXCHANGE AGREEMENT SHARE EXCHANGE AGREEMENT, dated as of January 30, 2009 (this “Agreement”) by and among Bioneutral Group, Inc. (formerly, Moonshine Creations, Inc.), a Nevada corporation (“Moonshine”), the controlling shareholder of Moonshine set forth on Schedule I hereto (the “Moonshine Controlling Stockholder”), Bioneutral Laboratories Corporation USA, a Delaware corporation |
|
| February 23, 2009 |
BioNeutral Group, Inc. 211 Warren Street Newark, New Jersey 07103 BioNeutral Group, Inc. 211 Warren Street Newark, New Jersey 07103 February 18, 2009 Ta Tanisha Meadows Securities and Exchange Commission 100 F Street N.E. Mail Stop 3561 Washington, D.C. 20549 Re: BioNeutral Group, Inc. Item 4.01 Form 8-K Filed February 5, 2009 File No. 333-149235 Dear Ms. Meadows: We are in receipt of your comment letter dated February 6, 2009 regarding the above referenced fili |
|
| February 23, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 26 , 2009 BioNeutral Group, Inc. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 333-149235 26-0745273 (STATE OR OTHER JURISDICTION OF INCORPORATI |
|
| February 5, 2009 |
Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI |
|
| February 5, 2009 |
EX-2.1 2 f8k013009ex2ibioneut.htm SHARE EXCHANGE AGREEMENT Exhibit 2.1 SHARE EXCHANGE AGREEMENT SHARE EXCHANGE AGREEMENT, dated as of January 30, 2009 (this “Agreement”) by and among Bioneutral Group, Inc. (formerly, Moonshine Creations, Inc.), a Nevada corporation (“Moonshine”), the controlling shareholder of Moonshine set forth on Schedule I hereto (the “Moonshine Controlling Stockholder”), Bion |
|
| February 5, 2009 |
Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) Exhibit 3.1 ROSS MILLER Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89701-4069 (775) 684-5708 Website: secretaryofstate.biz Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) Filed in the office of /s/ Ross Miller Ross Miller Secretary of State State of Nevada Document Number 20080839543-12 Filing Date and Time 12/29/2008 2:52 PM Entity Number EO252612007-8 USE |
|
| February 5, 2009 |
PART I — FINANCIAL INFORMATION Exhibit 99.2 PART I — FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS. Index to Financial Statements CONSOLIDATED BALANCE SHEETS 60; F–1 UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS F–2 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS F–3 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2008 AND 2007 F–4 BIONEUTRAL LABORATORIES CORPORATON USA CONSOLIDAT |
|
| February 5, 2009 |
BIONEUTRAL GROUP, INC. CODE OF ETHICS Exhibit 14.1 BIONEUTRAL GROUP, INC. CODE OF ETHICS As a public company, it is of critical importance that Bioneutral Group, Inc. (“Bioneutral”) filings with the Securities and Exchange Commission be accurate and timely. Depending on their position with Bioneutral, employees may be called upon to provide information to assure that Bionetural’s public reports are complete, fair, and understandable. |
|
| February 5, 2009 |
Exhibit 99.1 PART I ? FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS. Index to Financial Statements INDEPENDENT AUDITOR?S REPORT F?1 CONSOLIDATED BALANCE SHEETS F?2 CONSOLIDATED STATEMENTS OF OPERATIONS F?3 CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY F?4 CONSOLIDATED STATEMENTS OF CASH FLOWS F?5 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED 2007 AND 2006 F?6 INDEPENDEN |
|
| February 5, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 30, 2008 BioNeutral Group, Inc. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 333-149235 26-0745273 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION) |
|
| February 5, 2009 |
BIONEUTRAL GROUP, INC. AGREEMENT TO CONVERT BIONEUTRAL DEBENTURE Exhibit 4.2 BIONEUTRAL GROUP, INC. AGREEMENT TO CONVERT BIONEUTRAL DEBENTURE WHEREAS, Bioneutral Group, Inc. (the “Company”) offered for sale to , the undersigned debenture holder, (the “Holder”) a debenture in the principal amount of $100,000 dated December , 2008 (the “Debenture”). WHEREAS, on January , 2009, Bioneutral Group, Inc. (formerly, Moonshine Creations, Inc.) entered into a Share Excha |
|
| February 5, 2009 |
Exhibit 10.1 BIONEUTRAL GROUP, INC. 2009 Stock Incentive Plan Effective January , 2009 SECTION 1 General Provisions Relating to Plan Governance, Coverage and Benefits 1.1 Background and Purpose BioNeutral Group, Inc., a Nevada corporation, (the “Company”) established and adopted the BioNeutral Group, Inc. 2009 Stock Incentive Plan (the “Plan”) effective as of January , 2009 for the benefit of the |
|
| February 5, 2009 |
Exhibit 16.1 February 5, 2009 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 RE: BioNeutral Group, Inc. (f/k/a Moonshine Creations, Inc.) File Ref. No. 333-149235 We have read the statements of BioNeutral Group, Inc. (f/k/a Moonshine Creations, Inc.) pertaining to our firm included under Item 4.01 of Form 8-K dated February 5, 2009 and agree with such statements as the |
|
| January 15, 2009 |
635,500 SHARES OF MOONSHINE CREATIONS, INC. COMMON STOCK DATED: January 14, 2009 Filed Pursuant to Rule 424(b)(1) Registration No. 333-149235 635,500 SHARES OF MOONSHINE CREATIONS, INC. COMMON STOCK The selling shareholders named in this prospectus are offering all of the shares of common stock offered through this prospectus. Our common stock is presently not traded on any market or securities exchange and have no voting rights. The 635,500 shares of o |
|
| January 7, 2009 |
MOONSHINE CREATIONS, INC. FINANCIAL CODE OF ETHICS Exhibit 14 MOONSHINE CREATIONS, INC. FINANCIAL CODE OF ETHICS As a public company, it is of critical importance that Moonshine Creations, Inc. (?Moonshine?) filings with the Securities and Exchange Commission be accurate and timely. Depending on their position with Moonshine, employees may be called upon to provide information to assure that Moonshine?s public reports are complete, fair, and under |
|
| January 7, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-149235 MOONSHINE CREATIONS, INC. (N |
|
| December 29, 2008 |
MOONSHINE CREATIONS, INC. FINANCIAL CODE OF ETHICS Exhibit 14 MOONSHINE CREATIONS, INC. FINANCIAL CODE OF ETHICS As a public company, it is of critical importance that Moonshine Creations, Inc. (?Moonshine?) filings with the Securities and Exchange Commission be accurate and timely. Depending on their position with Moonshine, employees may be called upon to provide information to assure that Moonshine?s public reports are complete, fair, and under |
|
| December 29, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-149235 MOONSHINE CREATIONS, INC. (Name of small busine |
|
| September 11, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. MOONSHINE CREATIONS, INC. (Exact name of registrant as sp |
|
| June 9, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. MOONSHINE CREATIONS, INC. (Exact name of registrant as s |
|
| April 17, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-149235 MOONSHINE CREATIONS, I |
|
| February 14, 2008 |
STATE OF NEVADA ROSS MILLER Secretary of State OFFICE OF THE STATE SECRETARY OF STATE. |
|
| February 14, 2008 |
SECURITIES AND EXCHANGE COMMISSION ================================== FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ================================== Moonshine Creations, Inc. |
|
| February 14, 2008 |
BYLAWS OF MOONSHINE CREATIONS, INC. A Nevada Corporation As of April 10, 2007 ARTICLE I Meetings of Stockholders Section 1.1 Time and Place. Any meeting of the stockholders may be held at such time and such place, either within or without the State of Nevada, as shall be designated from time to time by resolution of the board of directors or as shall be stated in a duly authorized notice of the me |
